AbbVie
ABBV
#25
Rank
C$723.09 B
Marketcap
C$409.08
Share price
-2.33%
Change (1 day)
25.07%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): C$8.26

According to AbbVie's latest financial reports the company's current EPS (TTM) is C$8.37. In 2025 the company made an earnings per share (EPS) of C$3.39 a decrease over its 2024 EPS that were of C$3.46.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$8.26143.82%
2025C$3.39-2.26%
2024C$3.46-11.86%
2023C$3.93-58.95%
2022C$9.582.49%
2021C$9.34121.58%
2020C$4.22-44.7%
2019C$7.6245.84%
2018C$5.239.72%
2017C$4.76-9.54%
2016C$5.2716.28%
2015C$4.53184.1%
2014C$1.59-57.15%
2013C$3.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.18 427.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.86 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$3.38-59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$4.43-152.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.46-22.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.18 21.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$4.12-50.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$9.97 19.11%๐Ÿ‡บ๐Ÿ‡ธ USA